Published in Eur J Cancer Prev on October 01, 2004
Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer (2006) 1.33
More people die from thin melanomas (⩽1 mm) than from thick melanomas (>4 mm) in Queensland, Australia. J Invest Dermatol (2014) 1.16
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. Clin Epidemiol (2016) 0.78
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 14.03
Cancer burden in the year 2000. The global picture. Eur J Cancer (2001) 10.47
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia (2011) 3.52
Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax (2004) 2.77
Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol (2006) 2.30
Epidemiology of invasive cutaneous melanoma. Ann Oncol (2009) 2.21
[Guideline 'Melanoma' (3rd revision)]. Ned Tijdschr Geneeskd (2005) 2.08
[The practice guideline: 'Treatment of tobacco dependence']. Ned Tijdschr Geneeskd (2005) 2.06
Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008. Br J Dermatol (2012) 2.03
[Surgery and referral for subsequent 131I therapy for patients with differentiated thyroid carcinoma in the south-east of the Netherlands, 1983-1996, compared to the consensus guidelines from 1987]. Ned Tijdschr Geneeskd (2002) 1.94
On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control (2007) 1.93
[Long-term results of the multidisciplinary surgical treatment of non-small-cell bronchial carcinoma in the superior sulcus (Pancoast tumour): a retrospective study]. Ned Tijdschr Geneeskd (2007) 1.93
Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer (2005) 1.93
Determining the cause of death in randomized screening trial(s) for prostate cancer. BJU Int (2003) 1.90
Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study. Eur J Cancer (2003) 1.70
Are patients with skin cancer at lower risk of developing colorectal or breast cancer? Am J Epidemiol (2008) 1.69
Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer (2002) 1.66
Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol (2005) 1.66
Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival. Ann Oncol (2013) 1.65
Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer. Br J Surg (2006) 1.65
Aggressive angiomyxoma: multimodality treatments can avoid mutilating surgery. Eur J Surg Oncol (2006) 1.61
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases. Eur J Cancer (2007) 1.58
Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. Br J Surg (2007) 1.57
Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients. J Surg Oncol (2005) 1.52
Variations in treatment policies and outcome for bladder cancer in the Netherlands. Eur J Surg Oncol (2010) 1.47
Prognosis for long-term survivors of cancer. Ann Oncol (2007) 1.47
Safety and efficacy of isolated limb perfusion in elderly melanoma patients. Ann Surg Oncol (2002) 1.46
[The correlation of age and comorbidity with therapy and survival in cancer patients in North-Brabant and North-Limburg, 1995-2001]. Ned Tijdschr Geneeskd (2005) 1.44
Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg (2005) 1.44
[Trends in the incidence and death from cancer from 1989-2003 in The Netherlands]. Ned Tijdschr Geneeskd (2006) 1.42
[Oncoplastic surgery of the breast: a combination of oncological and plastic surgery]. Ned Tijdschr Geneeskd (2007) 1.40
[A comparative study of the expenditures on health research in 7 western countries in 1997 places the Netherlands at the bottom of the list]. Ned Tijdschr Geneeskd (2002) 1.39
Cancer in children and adolescents in Europe: developments over 20 years and future challenges. Eur J Cancer (2006) 1.38
Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer (2003) 1.32
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg (2003) 1.31
Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis (2012) 1.30
Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer (2008) 1.29
Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer (2004) 1.29
Staging of cutaneous melanoma. Ann Oncol (2009) 1.26
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report. Eur J Cancer (2003) 1.21
Improving outcome for patients with pancreatic cancer through centralization. Br J Surg (2011) 1.19
Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit Rev Oncol Hematol (2005) 1.19
Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol (2009) 1.18
Cancer patients seeking a second surgical opinion: results of a study on motives, needs, and expectations. J Clin Oncol (2003) 1.17
Biomarkers in melanoma. Ann Oncol (2009) 1.17
Clinical epidemiology of breast cancer in the elderly. Eur J Cancer (2007) 1.17
Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival. Breast Cancer Res Treat (2011) 1.16
Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol (2006) 1.15
A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br J Cancer (2010) 1.15
Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006. Ann Oncol (2010) 1.15
Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer (2006) 1.15
Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol (2005) 1.14
Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol (2006) 1.13
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer (2005) 1.10
Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response? Phys Med Biol (2011) 1.10
Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews. Ann Hematol (2003) 1.10
Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. Eur J Cancer (2005) 1.08
Small molecules and targeted therapies in distant metastatic disease. Ann Oncol (2009) 1.08
Does sunlight prevent cancer? A systematic review. Eur J Cancer (2006) 1.07
Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer (2010) 1.06
Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer (2003) 1.04
Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer. Br J Surg (2012) 1.04
Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia (2012) 1.03
Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989. Br J Cancer (2010) 1.03
The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry. J Cancer Surviv (2013) 1.03
Total pelvic exenteration for primary and recurrent malignancies. World J Surg (2009) 1.02
The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol (2005) 1.02
Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001. Breast Cancer Res Treat (2005) 1.00
Increased risk of second malignancies after in situ breast carcinoma in a population-based registry. Br J Cancer (2006) 0.99
[Trends, causes, approach and consequences related to the skin-cancer epidemic in the Netherlands and Europe]. Ned Tijdschr Geneeskd (2006) 0.98
Increased health care utilisation among 10-year breast cancer survivors. Support Care Cancer (2006) 0.97
Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat (2008) 0.97
Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. Eur J Cancer (2003) 0.97
Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha. Eur J Surg Oncol (2006) 0.96
Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann Oncol (2007) 0.96
Immunotherapy of distant metastatic disease. Ann Oncol (2009) 0.96
'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome. Colorectal Dis (2010) 0.95
Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001. Eur J Cancer (2005) 0.94
High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer (2006) 0.94
Lifestyle changes and reduction of colon cancer incidence in Europe: A scenario study of physical activity promotion and weight reduction. Eur J Cancer (2010) 0.94
Lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio. Eur J Surg Oncol (2011) 0.94
Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol (2013) 0.93
Behaviour partly explains educational differences in cancer incidence in the south-eastern Netherlands: the longitudinal GLOBE study. Eur J Cancer Prev (2004) 0.92
TNF dose reduction in isolated limb perfusion. Eur J Surg Oncol (2005) 0.91
Transforming-growth factor beta1 Leu10Pro polymorphism and breast cancer morbidity. Eur J Cancer (2006) 0.91
Protective effect of NSAIDs on cancer and influence of COX-2 C(-765G) genotype. Curr Cancer Drug Targets (2008) 0.91
Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989-2003. Br J Cancer (2007) 0.90
Cytokines and vascular permeability: an in vitro study on human endothelial cells in relation to tumor necrosis factor-alpha-primed peripheral blood mononuclear cells. Cell Biochem Biophys (2006) 0.89
Testicular cancer: trends in mortality are well explained by changes in treatment and survival in the southern Netherlands since 1970. Eur J Cancer (2007) 0.89
Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989-2007. Ann Oncol (2011) 0.88
Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma. Ann Oncol (2011) 0.88
Variation in management of early breast cancer in the Netherlands, 2003-2006. Eur J Surg Oncol (2010) 0.88
Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases. Br J Surg (2011) 0.88
Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis. Ann Oncol (2006) 0.87
Stable incidence of childhood and adult glioma in The Netherlands, 1989-2003. Acta Oncol (2006) 0.87